MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-TN-02-0062589
Axxelent Pharma Science Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹104.6 Cr
▲ 63% YoY
Net profit · FY 2026
₹7.8 Cr
Net margin 7.5%
EBITDA · FY 2026
₹41.8 Cr
EBITDA margin 40%
Authorised capital
₹176.5 Cr
Registered with MCA
Paid-up capital
₹72.16 Cr
Issued & subscribed
Open charges
₹428.76 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Employees · EPFO
330
Provident fund records
About Axxelent Pharma Science Private Limited
Data last updated:
Axxelent Pharma Science Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24110TN2019PTC131943. Its GSTIN is 33AASCA8040P1Z4 (Tamil Nadu). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹176.5 Cr and a paid-up capital of ₹72.16 Cr. It is led by directors including Jitesh Devendra (Managing Director) and Chaitanya Devendra (Whole-Time Director).
Its last annual general meeting (AGM) was held on 29 May 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at No. 3 Jagadeeswaran Street, T.Nagar Chennai, Tamil Nadu, India – 600017.
As per the financials filed for FY 2026, the company reported a revenue of ₹104.6 Cr, a growth of 63% compared to the previous year. For the same year it recorded a net profit of ₹7.8 Cr (net margin 7.5%) and EBITDA of ₹41.8 Cr (EBITDA margin 40%). Revenue has grown at a compounded annual rate (CAGR) of 149% over three years and 158% over five years.
The company has about 330 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Axxelent. As per MCA filings, the company has open charges of ₹428.76 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it. The company has 26 deals on record (17 funding rounds, 6 rights issues, 2 secondary share transfers), with disclosed funding of ₹160.68 Cr; the latest was in June 2024.
Axxelent Pharma Science Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TN-02-0062589). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website axxelent.com.
Company details
CIN U24110TN2019PTC131943
Registration Number 131943
Incorporation Date 07 October 2019
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 May 2026
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-TN-02-0062589
Key People
Jitesh Devendra Managing Director Chaitanya Devendra Whole-Time Director Sreenivasa Reddy Bhimanatham Whole-Time Director Recognitions & Rankings of Axxelent Pharma Science
Contact details
Axxelent Pharma Science Private Limited's registered office is in Chennai, Tamil Nadu. Its website is axxelent.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo. 3 Jagadeeswaran Street, T.Nagar Chennai, Tamil Nadu, India – 600017
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
To see the full contact details of Axxelent Pharma Science Private Limited, buy the company report.
Comprehensive company report
Axxelent Pharma Science Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Axxelent Pharma Science operates one associated brand: Axxelent. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides CDMO services focused on pharmaceutical formulations and regulatory support. | axxelent.com |
Business activity
The main business activity of Axxelent Pharma Science is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Axxelent Pharma Science Private Limited, buy the company report.
Financials of Axxelent Pharma Science Private Limited
FY 2026 filings availableAxxelent Pharma Science Private Limited reported revenue of ₹104.6 Cr (up 63% YoY) for FY 2026.
Revenue · FY 2026
₹104.6 Cr ▲ 63%
Net profit · FY 2026
₹7.8 Cr margin 7.5%
EBITDA · FY 2026
₹41.8 Cr margin 40%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 63%
3 years · compounded
▲ 149%
5 years · compounded
▲ 158%
EBITDA CAGR growth
1 year
▲ 37%
Revenue has grown at a compounded annual rate (CAGR) of 158% over five years, including 63% growth in the latest year. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹104.6 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹41.8 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.8 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 40% | ||||
| Net Profit Margin | 7.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Axxelent Pharma Science Private Limited, buy the company report.
Board of directors of Axxelent Pharma Science Private Limited
Axxelent Pharma Science has 6 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sampath Kumar Devarajan | Director | 07 Oct 2019 | 7 Years 1 Months | Current |
| Subramanian Hariharan | Director | 01 Jul 2021 | 5 Years 4 Months | Current |
| Chaitanya Devendra Also directs: Axxinovar Pharma Private Limited, Avanthiya Pharma Private Limited | Whole-Time Director | 22 Apr 2022 | 4 Years 6 Months | Current |
| Jitesh Devendra Also directs: Axxinovar Pharma Private Limited | Managing Director | 04 Dec 2020 | 5 Years 11 Months | Current |
| Sreenivasa Reddy Bhimanatham | Whole-Time Director | 04 Dec 2020 | 5 Years 11 Months | Current |
| Kamlesh Phulwani Also directs: Medsurge Global Operations LLP | Nominee Director | 10 Apr 2023 | 3 Years 6 Months | Current |
Auditor
Axxelent Pharma Science Private Limited is audited by T A S S K & Associates LLP for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T A S S K & Associates LLP | FY 2026 | S200055 |
Shareholding
The shareholding of Axxelent Pharma Science Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Axxelent Pharma Science Private Limited, buy the company report.
Charges & borrowings
Open charges
₹428.76 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Aug 2026 | 101366236 | Others | ₹120 Cr | Open | |
| 23 Feb 2026 | 101239958 | Sidbi | ₹1.92 Cr | Open | |
| 16 Dec 2025 | 101262375 | Hdfc Bank Limited | ₹38.69 Lakh | Open | |
| 07 Jul 2025 | 101132490 | Others | ₹30 Cr | Open | |
| 07 Jul 2025 | 101132515 | Others | ₹100 Cr | Open |
To see the full charge records of Axxelent Pharma Science Private Limited, buy the company report.
Total charge records: 9 View all charges
Deals & funding
Axxelent Pharma Science Private Limited has 26 deals on record (17 funding rounds, 6 rights issues, 2 secondary share transfers), with disclosed funding of ₹160.68 Cr; the latest was in June 2024.
Total deals
26
Funding rounds
17
Rights issues
6
Secondary share transfers
2
Acquisition
1
Disclosed funding
₹160.68 Cr
Deals on record (5 of 26)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2024 | Funding round | ₹8.33 Cr | Investors: KR Impex Holding FZ-LLC |
| Sep 2023 | Funding round | ₹10.66 Cr | Investors: Kr Impex India Pty Ltd |
| Apr 2023 | Funding round | ₹22.07 Cr | Investors: Kr Impex India Pty Ltd |
| Apr 2023 | Funding round | ₹10.64 Cr | Investors: Kr Impex India Pty Ltd |
| Mar 2023 | Funding round | ₹5.47 Cr | Investors: Kr Impex India Pty Ltd |
To see the full deal history of Axxelent Pharma Science Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Axxelent Pharma Science Private Limited has 4 court cases on record: 3 filed by Axxelent Pharma Science, 1 filed against it. All cases are disposed.
Total cases
4
Filed by the company
3
Filed against the company
1
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 0 |
| NCLAT | 1 | 1 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, NCLAT Chennai | Company appeal | Filed against the company by Assistant Commissioner of Income Tax | Disposed |
| Madras High Court | Appeal | Filed by the company against an individual | Disposed |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against The State of Andhra Pradesh and 2 others | Disposed |
| High Court, TAMIL NADU | Appeal | Filed by the company against individuals | Disposed |
To see the full case history of Axxelent Pharma Science Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Axxelent Pharma Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Axxelent Pharma Science Private Limited has a workforce of 330 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
Employee count
330
Active EPFO establishments
1
Employee growth
55.66%
GST
Axxelent Pharma Science has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AASCA8040P1Z4 | Tamil Nadu | Active | 15 Oct 2019 |
| 37AASCA8040P1ZW | Andhra Pradesh | Active | 24 Aug 2020 |
To see the full GST registrations and return filing status of Axxelent Pharma Science Private Limited, buy the company report.
Recent activity
Axxelent Pharma Science Private Limited has 12 board changes on record since 2019: 6 appointments and 6 cessations. The latest: Sreenivasa Reddy Bhimanatham ceased to be Whole-Time Director on 03 Dec 2025.
Charges
A charge with Others amounted to Rs. 120.00 Cr with Charge ID 101366236 was registered on 10 Aug 2026.
Charges
A charge with Others of Rs. 30.00 Cr registered on 07 Jul 2025 with Charge ID 101132490 was modified on 14 Jul 2026.
Charges
A charge with Others of Rs. 100.00 Cr registered on 07 Jul 2025 with Charge ID 101132515 was modified on 14 Jul 2026.
AGM
Axxelent Pharma Science Private Limited last Annual general meeting of members was held on 29 May 2026 as per latest MCA records.
Filing
Axxelent Pharma Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Chennai.
Charges
A charge with Sidbi amounted to Rs. 1.92 Cr with Charge ID 101239958 was registered on 23 Feb 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.39 Cr with Charge ID 101262375 was registered on 16 Dec 2025.
Ceased
Sreenivasa Reddy Bhimanatham ceased to be Whole-Time Director.
Ceased
Punnaivanam Harihara Ponnambalam ceased to be CFO.
Charges
A charge with Others amounted to Rs. 30.00 Cr with Charge ID 101132490 was registered on 07 Jul 2025.
Charges
A charge with Others amounted to Rs. 100.00 Cr with Charge ID 101132515 was registered on 07 Jul 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.25 Cr with Charge ID 100900286 was registered on 13 Dec 2023.
15 earlier events are in the company report.
Frequently asked questions
Axxelent Pharma Science is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 October 2019 (7+ years old) and is registered under CIN U24110TN2019PTC131943.
Axxelent Pharma Science has 6 current directors:
- Jitesh Devendra - Managing Director
- Chaitanya Devendra - Whole-Time Director
- Sreenivasa Reddy Bhimanatham - Whole-Time Director
- Sampath Kumar Devarajan - Director
- Subramanian Hariharan - Director
- Kamlesh Phulwani - Nominee Director
The latest financial statements of Axxelent Pharma Science on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 May 2026. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Axxelent Pharma Science is 33AASCA8040P1Z4, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AASCA8040P1ZW (Andhra Pradesh).
The CIN (Corporate Identification Number) of Axxelent Pharma Science is U24110TN2019PTC131943. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Axxelent Pharma Science has 4 court cases on record: 3 filed by the company and 1 filed against it. Most are in the high courts.
Axxelent Pharma Science was incorporated on 07 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chennai.
Axxelent Pharma Science has 26 deals on record (17 funding rounds, 6 rights issues, 2 secondary share transfers), with disclosed funding of ₹160.68 Cr; the latest was in June 2024.
Sreenivasa Reddy Bhimanatham ceased to be Whole-Time Director on 03 Dec 2025. Punnaivanam Harihara Ponnambalam ceased to be CFO on 05 Sep 2025. Kamlesh Phulwani was appointed as Nominee Director on 10 Apr 2023. Axxelent Pharma Science has 12 board changes on record in total.
Yes, Axxelent Pharma Science is registered as an MSME under Udyam registration (number: UDYAM-TN-02-0062589).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages